Lataa...
Imaging of Programmed Cell Death Ligand 1: Impact of Protein Concentration on Distribution of Anti-PD-L1 SPECT Agents in an Immunocompetent Murine Model of Melanoma
Programmed cell death ligand 1 (PD-L1) is part of an immune checkpoint system that is essential for preventing autoimmunity and cancer. Recent approaches in immunotherapy that target immune checkpoints have shown great promise in a variety of cancers, including metastatic melanoma. The use of target...
Tallennettuna:
| Julkaisussa: | J Nucl Med |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Society of Nuclear Medicine
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5632734/ https://ncbi.nlm.nih.gov/pubmed/28522738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.193268 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|